2.99
price down icon1.97%   -0.06
pre-market  プレマーケット:  2.99  
loading
前日終値:
$3.05
開ける:
$3.0951
24時間の取引高:
31,483
Relative Volume:
0.07
時価総額:
$9.10M
収益:
-
当期純損益:
$2.81M
株価収益率:
-0.2084
EPS:
-14.3497
ネットキャッシュフロー:
$7.14M
1週間 パフォーマンス:
-5.97%
1か月 パフォーマンス:
-1.32%
6か月 パフォーマンス:
-21.93%
1年 パフォーマンス:
-36.25%
1日の値動き範囲:
Value
$2.99
$3.10
1週間の範囲:
Value
$2.96
$3.2328
52週間の値動き範囲:
Value
$2.51
$4.80

Kiora Pharmaceuticals Inc Stock (KPRX) Company Profile

Name
名前
Kiora Pharmaceuticals Inc
Name
セクター
Healthcare (1163)
Name
電話
781-788-8869
Name
住所
332 ENCINITAS BOULEVARD, ENCINITAS
Name
職員
12
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
KPRX's Discussions on Twitter

KPRX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
KPRX
Kiora Pharmaceuticals Inc
2.99 9.28M 0 2.81M 7.14M -14.35
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Kiora Pharmaceuticals Inc (KPRX) 最新ニュース

pulisher
04:46 AM

Strategies to average down on Kiora Pharmaceuticals Inc. Machine Learning Intraday Signal Forecast - Newser

04:46 AM
pulisher
Jul 27, 2025

What is the risk reward ratio of investing in Kiora Pharmaceuticals Inc. stockMaximize portfolio value with smart investment plans - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Kiora Pharmaceuticals Inc.Phenomenal trading returns - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Kiora Pharmaceuticals Inc. Stock Support and Resistance Levels You Should KnowFree Trading Group - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Why Kiora Pharmaceuticals Inc. stock attracts strong analyst attentionProfitable Yet Secure Picks - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Can Kiora Pharmaceuticals Inc. stock recover from recent declineCapital Protected Stock Selections - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Kiora Pharmaceuticals Inc. Company Revenue and Profit Trends: A Deep DiveProfitable Yet Secure Picks - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

What makes Kiora Pharmaceuticals Inc. stock price move sharplyBreakout Momentum Alerts - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Is Kiora Pharmaceuticals Inc. a good long term investmentDouble-digit growth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Kiora Pharmaceuticals Inc. stock priceDynamic investment opportunities - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Kiora Pharmaceuticals Inc. stockPhenomenal trading returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 24, 2025

Kiora Pharmaceuticals Secures US Patent for KIO-104 - Ophthalmology Times

Jul 24, 2025
pulisher
Jul 23, 2025

Kiora Pharmaceuticals Inc. Stock Analysis and ForecastExtraordinary market timing - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

KPRX Receives Positive Outlook Following New U.S. Patent | KPRX Stock News - GuruFocus

Jul 22, 2025
pulisher
Jul 22, 2025

Kiora Pharmaceuticals stock rises after receiving patent for KIO-104 - Investing.com India

Jul 22, 2025
pulisher
Jul 22, 2025

Kiora Pharmaceuticals stock rises after receiving patent for KIO-104 By Investing.com - Investing.com Nigeria

Jul 22, 2025
pulisher
Jul 22, 2025

Kiora Pharmaceuticals receives patent for ocular disease treatment By Investing.com - Investing.com South Africa

Jul 22, 2025
pulisher
Jul 22, 2025

Kiora Pharmaceuticals receives patent for ocular disease treatment - Investing.com Australia

Jul 22, 2025
pulisher
Jul 22, 2025

Kiora Secures Crucial Patent for Eye Disease Drug KIO-104 as Phase 2 Trial Advances - Stock Titan

Jul 22, 2025
pulisher
Jul 17, 2025

Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know - MSN

Jul 17, 2025
pulisher
Jul 16, 2025

Retinitis Pigmentosa Treatment Market Driven by Gene Therapy - openPR.com

Jul 16, 2025
pulisher
Jul 15, 2025

How Kiora Pharmaceuticals Inc. stock performs during market volatilityFree Smart Money Stock Analysis - Newser

Jul 15, 2025
pulisher
Jul 09, 2025

Kiora Pharmaceuticals (NASDAQ:KPRX) Trading 1.8% Higher – Here’s Why - Defense World

Jul 09, 2025
pulisher
Jun 17, 2025

Kiora Pharmaceuticals (NASDAQ:KPRX) Trading Down 0.3% – Here’s Why - Defense World

Jun 17, 2025

Kiora Pharmaceuticals Inc (KPRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
大文字化:     |  ボリューム (24 時間):